Die transvenöse elektrische Kardioversion (TVEC) bei Pferden mit Vorhofflimmern

Vorhofflimmern ist die bei Pferden am häufigsten auftretende, klinisch relevante Arrhythmie. Neben der Behandlung mit Chinidinsulfat ist die transvenöse elektrische Kardioversion eine erfolgversprechende Therapieoption.

Publikationsverlauf

Artikel online veröffentlicht:
18. Juni 2021

• Literatur

• 1 Reef VB, Levitan CW, Spencer PA. Factors affecting prognosis and conversion in equine atrial fibrillation. J Vet Intern Med 1988; 2: 1-6
• 2 Reef VB, Reimer JM, Spencer PA. Treatment of atrial fibrillation in horses: New perspectives. J Vet Intern Med 1995; 9: 57-67
• 3 Physick-Sheard PW. Atrial fibrillation. In: Colahan PT, Mayhew IG, Merritt AM, Moore JN. eds. Equine Medicine and Surgery, 5th ed. St. Louis, Mo: Mosby; 1999: 354-358
• 4 Reef V, Bonagura J, Buhl R, McGurrin M, Schwarzwald C, van Loon G, Young L. Recommendations for Management of Equine Athletes with Cardiovascular Abnormalities. J Vet Intern Med 2014; 28: 749-761
• 5 Niebuhr T, Ohnesorge B. Management von Reitpferden mit Herzerkrankungen – Empfehlungen von ECEIM, ACVIM und Consensus Statement. Pferdespiegel 2020; 23 (04) 178-188
• 6 Kimberly M, McGurrin J, Physick-Sheard PW, Kenney DJ, Kerr C, Hanna B, Neto F, Weese S. Transvenous electrical cardioversion in atrial fibrillation: technique and successful treatment of 3 horses. J Vet Intern Med 2003; 17: 715-718
• 7 Kimberly M, McGurrin J, Physick-Sheard PW, Kenney DG. How to perform transvenous electrical cardioversion in horses with atrial fibrillation. J Vet Cardiol 2005; 7: 109-119
• 8 McGurrin M, Physick-Sheard P, Kenney D. Transvenous Electrical Cardioversion of Equine Atrial Fibril-lation: Patient Factors and Clinical Results in 72 Treatment Episodes. J Vet Intern Med 2008; 22: 609-615
• 9 Kimberly M, McGurrin J, Physick-Sheard PW, Kenney DG, Kerr C, Hanna WB. Transvenous Electrical Cardioversion of Equine Atrial Fibrillation Technical Considerations. J Vet Intern Med 2005; 19: 695-702
• 10 Preiss E, Kenney DG, Kimberly M, McGurrin J, Physick-Sheard PW. Influence of electrode position on cardioversion energy requirements during transvenous electrical cardioversion in horse. Am J Vet Res 2011; 72 (09) 1193-1203
• 11 De Clercq D, van Loon G, Schauvliege S. et al. Transvenous electrical cardioversion of atrial fibrillation in six horses using custom made cardioversion catheters. Vet J 2008; 177: 198-204
• 12 Bellei MH, Kerr C, McGurrin MK. et al. Management and complications of anesthesia for transvenous electrical cardioversion of atrial fibrillation in horses: 62 cases (2002–2006). J Am Vet Med Assoc 2007; 231: 1225-1230
• 13 Decloedt A VT, Van Der Vekens N, De Clercq D, van Loon G. Long-term follow-up of atrial function after cardioversion of atrial fibrillation in horses. Vet J 2013; 197: 583-588
• 14 Schwarzwald CC, Schober KE, Bonagura JD. Echocardiographic evidence of left atrial mechanical dys-function after conversion of atrial fibrillation to sinus rhythm in 5 horses. J Vet Intern Med 2007; 21: 820-827
• 15 De Clercq D, Decloedt A, Sys S, Verheyen T, Van Der Vekens N, van Loon G. Atrial Fibrillation Cycle Length and Atrial Size in Horses with and without Recurrence of Atrial Fibrillation after Electrical Cardio-version. J Vet Intern Med 2014; 28: 624-629
• 16 Vernemmen I, De Clercq D, Decloedt A, Vera L, Van Steenkiste G, van Loon G. Atrial premature depolarisations five days post electrical cardioversion are related to atrial fibrillation recurrence risk in horses. Equine Vet J 2020; 52: 374-378
• 17 Decloedt A, Schwarzwald CC, De Clercq D, Van Der Vekens N, Pardon B, Reef VB, van Loon G. Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm. J Vet Intern Med 2015; 29 (03) 946-953
• 18 Decloedt A, Verheyen T, Van Der Vekens N, Sys S, De Clercq D, van Loon G. Long-term follow-up of atrial function after cardioversion of atrial fibrillation in horses. Vet J 2013; 197 (03) 583-588
• 19 Neuckermans Z. et al. Amiodarone during transvenous electrical cardioversion of atrial fibrillation in horses to reduce cardioversion threshold or prevent immediate recurrence. 13th ECEIM Congress; 2020
• 20 Marly-Voquer C, Schwarzwald CC, Bettschart-Wolfensberger R. The use of dexmedetomidine continuous rate infusion for horses undergoing transvenous electrical cardioversion-A case series. Can Vet J 2016; 57 (01) 70-75
• 21 Decloedt A, Broux B, De Clercq D, Deprez P, Van Steenkiste G, Vera L, van Loon G. Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation. J Vet Intern Med 2018; 32 (02) 815-821
• 22 Dufourni A, Broux B, Decloedt A, De Clercq D, van Loon G. Influence of orally administered sotalol hydrochloride on QT intervals at rest and in anesthetized horses after transvenous electrical cardioversion (TVEC). 9th Congress of the European College of Equine Internal Medicine; 2016: 104
• 23 Schwarzwald CC, Schober KE, Bonagura JD. Methods and reliability of echocardiographic as-sessment of left atrial size and mechanical function in horses. Am J Vet Res 2007; 68 (07) 735-747
• 24 Jesty S, Kraus M, Gelzer A, Rishniw M, Moïse N. Effect of Transvenous Electrical Cardioversion on Plasma Cardiac Troponin I Concentrations in Horses with Atrial Fibrillation. J Vet Intern Med 2009; 23: 1103-1107